BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Target therapy
1
New approaches for patients with advanced radioiodine-refractory thyroid cancer
1/22/2022 6:17:12 AM | Browse: 393 | Download: 923
2
Molecular heterogeneity in intrahepatic cholangiocarcinoma
12/18/2020 5:58:43 AM | Browse: 768 | Download: 1718
3
Advance in metabolism and target therapy in breast cancer stem cells
11/26/2020 10:14:32 AM | Browse: 712 | Download: 1736
4
Bone marrow microenvironment: The guardian of leukemia stem cells
8/26/2019 10:16:55 AM | Browse: 930 | Download: 1364
5
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
7/12/2017 6:45:23 AM | Browse: 1150 | Download: 2063
6
Changing strategies for target therapy in gastric cancer
1/15/2016 3:02:00 PM | Browse: 1046 | Download: 1890
7
Mitochondrial uncoupling protein 2 and pancreatic cancer: A new potential target therapy
12/10/2015 10:35:00 AM | Browse: 1324 | Download: 1927
8
Advanced non-small cell lung cancer in elderly patients: A review
8/4/2015 12:50:00 PM | Browse: 1206 | Download: 2051
9
Role of E3 ubiquitin ligases in gastric cancer
1/20/2015 9:10:00 PM | Browse: 1319 | Download: 1536
10
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
11/10/2014 7:09:00 PM | Browse: 1100 | Download: 1657
11
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
8/29/2014 2:41:00 PM | Browse: 1164 | Download: 1364
12
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
8/29/2014 11:31:00 AM | Browse: 971 | Download: 1377
13
Novel agents and new therapeutic approaches for treatment of multiple myeloma
8/20/2014 9:00:00 PM | Browse: 1158 | Download: 1539
14
Personalizing medicine for metastatic colorectal cancer: Current developments
8/18/2014 5:14:00 PM | Browse: 1229 | Download: 1278
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345